Dinitrochlorobenzene sensitization in children with bronchial asthma

Area of Science:

• Immunology
• Pulmonology
• Allergy and Clinical Immunology

Background:

• Bronchial asthma is a chronic respiratory disease characterized by airway inflammation.
• Cell-mediated immunity plays a crucial role in immune responses and defense against pathogens.
• Previous studies have suggested potential immune dysregulation in asthma patients.

Purpose of the Study:

• To investigate cell-mediated immunity in patients with bronchial asthma.
• To assess the reactivity of asthmatic patients to a standard skin test antigen.
• To explore the potential correlation between immune function and asthma pathogenesis.

Main Methods:

• Twenty-one patients diagnosed with bronchial asthma were enrolled in the study.
• Dinitrochlorobenzene (DNCB) skin sensitization test was performed on all participants.
• Reactivity to PPD (purified protein derivative) was also assessed in a subset of patients, including those previously vaccinated with BCG (Bacille Calmette-Guérin).

Main Results:

• A significant proportion of asthma patients (11 out of 21, 52%) showed no reaction to the dinitrochlorobenzene skin test.
• Five patients with a history of BCG vaccination did not react to PPD, indicating a potential broader issue with cell-mediated immunity.
• These findings suggest an impairment in cell-mediated immune responses among individuals with bronchial asthma.

Conclusions:

• The study indicates that cell-mediated immunity may be impaired in patients with bronchial asthma.
• This immunological finding could have implications for understanding the underlying mechanisms and pathogenesis of asthma.
• Further research is warranted to elucidate the precise relationship between immune dysfunction and asthma development.